KeyBanc initiated coverage of Axonics with an Overweight rating and $70 price target. The analyst believes Axonics is well positioned to continue driving “rapid penetration of its portfolio in a large underserved market.” The firm sees opportunity for an improvement in investor sentiment as some near-tension points around new competition and an ongoing intellectual property lawsuit are addressed.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on AXNX: